There is no single interaction answer for every product sold as “NAD support.” Some contain NR or NMN alone; others add niacin, botanical extracts, minerals, caffeine, or several of these together.
The right starting point is the complete ingredient list plus your medicines and other supplements. Limited interaction research on a particular NAD precursor is not a guarantee that any combination is safe.
Have the complete formulation reviewed. A product’s extra ingredients may matter as much as the NAD-related ingredient.
What information makes an interaction review useful?
Bring photographs of the full label, the amount you actually use, frequency, and route. Include prescription medicines, over-the-counter products, and other supplements, even if they come from different providers. The FDA’s interaction guidance recommends sharing this information with a healthcare professional. “One NAD pill” is not enough to identify the exposure.
A known example: added nicotinic acid
The NIH niacin fact sheet describes how high doses of nicotinic acid can worsen glucose control and affect management with diabetes medicines. That finding should be tied to nicotinic acid, rather than casually assigned to all NR, NMN, or NAD products. A combined B3 entry on a label may require clarification of the individual forms. See NAD and insulin resistance.
What about blood thinners and other prescription medicines?
FDA guidance gives examples of supplements that can affect medication action or bleeding risk. It does not establish that every NAD precursor shares those effects. If a formula adds herbs, polyphenols, or high amounts of vitamins, ask for an ingredient-by-ingredient review against the actual prescription. Avoid both extremes: declaring an entire product category interaction-free, or inventing a specific interaction because two ingredients affect related pathways in a laboratory.
Why stacking makes the label harder to interpret
A multivitamin, energy blend, and NAD formula may repeat ingredients under different names. Add up the labeled servings you use before the appointment, while keeping each form identified. Do not assume a large combined milligram total predicts either efficacy or harm. The ProHealth formula review illustrates why B3 forms and multiple precursors need separate attention.
Tell the surgical team before a procedure
Some supplements can affect medicines used around surgery. FDA guidance advises discussing supplements with the care team beforehand. The correct stop or restart plan depends on the procedure, formulation, and other treatment; do not use an internet-wide “stop all NAD for X days” rule. Tell the team about prescribed compounded products as well as retail capsules.
If a new symptom appears
Keep the product, label, lot number, and a record of when the symptom started. For a suspected supplement reaction, FDA advises stopping the supplement and seeking medical advice or care. Get emergency help for severe symptoms such as trouble breathing, collapse, or facial or throat swelling. Do not independently stop an essential prescription medicine to make room for a supplement. Side-effect planning and flushing questions offer related context.
Sources & reading notes
Primary sources checked September 18, 2026. Provider pages describe their own offers; inclusion does not verify a product or its results.
- FDA: mixing medications and dietary supplements General interaction and surgery guidance; specific risks must be matched to the actual ingredient and medication.
- NIH Office of Dietary Supplements: niacin Nutritional and biochemical context; not a clinical trial of NAD+ injections.
- FDA 101: dietary supplements Adverse-event response and supplement safety context.
Educational information, not individualized medical advice. We do not claim medical review or firsthand treatment experience. Read our review standards and commercial disclosure.